{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:06:28Z","timestamp":1758845188493,"version":"3.44.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"Introduction<\/jats:title>Netherton syndrome (NS) is a rare autosomal recessive disorder caused by mutations in the SPINK5<\/jats:italic> gene, which encodes the serine protease inhibitor LEKTI. It is characterized by congenital ichthyosis, hair shaft abnormalities, and atopic manifestations. Previous reports suggest that intravenous immunoglobulin (IVIG) may provide partial clinical benefit in NS. Here, we report the clinical and immunological characterization of an infant with NS effectively treated with IVIG therapy. <\/jats:p><\/jats:sec>Methods<\/jats:title>Clinical information was collected and reviewed from a 1-year-6-month-old boy presenting with NS. Hair shaft abnormalities were examined by scanning electron microscopy. Pathogenic variants in SPINK5<\/jats:italic> were identified using whole-exome and Sanger sequencing. Protein expression was assessed by Western blotting and ELISA. Peripheral lymphocyte subsets were analyzed by flow cytometry, and cytokine levels were evaluated with the Olink\u00ae Target 48 Cytokine panel. <\/jats:p><\/jats:sec>Results<\/jats:title>The patient presented with typical clinical manifestations of NS. Genetic analysis identified a novel heterozygous deletion spanning the SPINK5<\/jats:italic> gene (chr5:147,443,561-147,719,327), together with the c.1258A&gt;G (p.K420E) polymorphism. LEKTI expression was markedly decreased, consistent with the genetic findings. Immune profiling revealed markedly reduced unswitched memory and marginal zone-like B cells, increased na\u00efve B cells, and elevated \u03b3\u03b4 T cells compared with healthy controls. Cytokine analysis showed significantly increased levels of multiple pro-inflammatory cytokines, including TGFA, IL17 family members, CXCL8, CCL2, TNF, CCL19, and IL18. Following IVIG therapy, the patient demonstrated significant clinical improvement, with recovery of skin manifestations, and partial normalization of lymphocyte subsets and cytokine levels, indicating restoration of immune regulation. <\/jats:p><\/jats:sec>Discussion<\/jats:title>This study reports a novel compound heterozygous SPINK5<\/jats:italic> mutation in an infant with NS, comprising a large deletion and c.1258A&gt;G polymorphism, resulting in LEKTI deficiency and immune dysregulation. IVIG therapy effectively alleviated clinical symptoms and restored immune balance, highlighting its potential as a therapeutic option for NS and related immunodeficiency disorders.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1658444","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:29:39Z","timestamp":1758778179000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and immunological characterization of a Netherton syndrome infant with a large SPINK gene cluster deletion and a c.1258A>G polymorphism in SPINK5"],"prefix":"10.3389","volume":"16","author":[{"given":"Yaning","family":"Guan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maolin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuochen","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.645259","article-title":"Netherton syndrome in children: management and future perspectives","volume":"9","author":"Barbati","year":"2021","journal-title":"Front Pediatr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.01389.x","article-title":"The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis","volume":"117","author":"Sprecher","year":"2001","journal-title":"J Invest Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1159\/000507359","article-title":"Netherton\u2019s syndrome: A case of two male siblings diagnosed in adulthood","volume":"12","author":"Flora","year":"2020","journal-title":"Case Rep Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000514699","article-title":"Netherton syndrome: case report and review of the literature","volume":"7","author":"Herz-Ruelas","year":"2021","journal-title":"Skin Appendage Disord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.943264","article-title":"A novel mutation in SPINK5 gene underlies a case of atypical Netherton syndrome","volume":"13","author":"Wang","year":"2022","journal-title":"Front Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/00128071-200304020-00002","article-title":"Ichthyosis: etiology, diagnosis, and management","volume":"4","author":"DiGiovanna","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.864449","article-title":"Outcomes of systemic treatment in children and adults with netherton syndrome: A systematic review","volume":"13","author":"Nouwen","year":"2022","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-016-0243-y","article-title":"Netherton syndrome: A genotype-phenotype review","volume":"21","author":"Sarri","year":"2017","journal-title":"Mol Diagn Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17457","article-title":"New compound heterozygous SPINK5 mutations in a Chinese infant with Netherton syndrome","volume":"35","author":"Wang","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/genes14051080","article-title":"Netherton syndrome caused by heterozygous frameshift mutation combined with homozygous c.1258A>G polymorphism in SPINK5 gene","volume":"14","author":"Moltrasio","year":"2023","journal-title":"Genes (Basel)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.06.009","article-title":"Com\u00e8l-Netherton syndrome defined as primary immunodeficiency","volume":"124","author":"Renner","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13023-018-0956-6","article-title":"Immune cell phenotype and functional defects in Netherton syndrome","volume":"13","author":"Er\u00e4nk\u00f6","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(95)70159-1","article-title":"Netherton\u2019s syndrome: a syndrome of elevated IgE and characteristic skin and hair findings","volume":"95","author":"Smith","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.019","article-title":"An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis","volume":"139","author":"Paller","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.03.1523","article-title":"The major orphan forms of ichthyosis are characterized by systemic T-cell activation and Th-17\/Tc-17\/Th-22\/Tc-22 polarization in blood","volume":"138","author":"Czarnowicki","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"Cd009864","DOI":"10.1002\/14651858.CD009864.pub2","article-title":"Topical tacrolimus for atopic dermatitis","volume":"2015","author":"Cury Martins","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2006.02956.x","article-title":"Netherton syndrome: successful use of topical tacrolimus and pimecrolimus in four siblings","volume":"46","author":"Bin Saif","year":"2007","journal-title":"Int J Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18892","article-title":"Successful treatment of Netherton syndrome with ustekinumab in a 15-year-old girl","volume":"183","author":"Volc","year":"2020","journal-title":"Br J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.18926\/AMO\/56073","article-title":"Analysis of all 34 exons of the SPINK5 gene in Japanese atopic dermatitis patients","volume":"72","author":"Morizane","year":"2018","journal-title":"Acta Med Okayama"},{"key":"B20","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jaci.2018.04.022","article-title":"Reference values for peripheral blood lymphocyte subsets of healthy children in China","volume":"142","author":"Ding","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1600","article-title":"Netherton syndrome caused by compound heterozygous mutation, c.80A>G mutation in SPINK5 and large-sized genomic deletion mutation, and successful treatment of intravenous immunoglobulin","volume":"9","author":"Zhang","year":"2021","journal-title":"Mol Genet Genomic Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ng728","article-title":"Gene polymorphism in Netherton and common atopic disease","volume":"29","author":"Walley","year":"2001","journal-title":"Nat Genet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09231.x","article-title":"A heterozygous null mutation combined with the G1258A polymorphism of SPINK5 causes impaired LEKTI function and abnormal expression of skin barrier proteins","volume":"161","author":"Di","year":"2009","journal-title":"Br J Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005389","article-title":"KLK5 inactivation reverses cutaneous hallmarks of netherton syndrome","volume":"11","author":"Furio","year":"2015","journal-title":"PloS Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.133","article-title":"Epidermal barrier dysfunction in atopic dermatitis","volume":"129","author":"Cork","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700284","article-title":"Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome","volume":"126","author":"Descargues","year":"2006","journal-title":"J Invest Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/exd.70113","article-title":"Blocking of IL-4\/IL-13 signalling with dupilumab results in restoration of serum and cutaneous abnormalities in netherton syndrome","volume":"34","author":"Blunder","year":"2025","journal-title":"Exp Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701153","article-title":"Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients","volume":"128","author":"Komatsu","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.5827","article-title":"Intrafamily and interfamilial phenotype variation and immature immunity in patients with netherton syndrome and finnish SPINK5 founder mutation","volume":"152","author":"Hannula-Jouppi","year":"2016","journal-title":"JAMA Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s42003-024-05780-y","article-title":"Comparative analyses of Netherton syndrome patients and Spink5 conditional knock-out mice uncover disease-relevant pathways","volume":"7","author":"Petrova","year":"2024","journal-title":"Commun Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1297658","article-title":"Case report: Interleukin-17 targeted biological therapy in netherton syndrome","volume":"11","author":"Mahajan","year":"2023","journal-title":"Front Pediatr"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3109\/08923973.2015.1115518","article-title":"A case of netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels","volume":"38","author":"Yalcin","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2009.240","article-title":"Role of chemokines in CNS health and pathology: a focus on the CCL2\/CCR2 and CXCL8\/CXCR2 networks","volume":"30","author":"Semple","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30089","article-title":"TWEAK\/Fn14 axis is an important player in fibrosis","volume":"236","author":"Zhang","year":"2021","journal-title":"J Cell Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00212","article-title":"CCL19 and CCR7 expression, signaling pathways, and adjuvant functions in viral infection and prevention","volume":"7","author":"Yan","year":"2019","journal-title":"Front Cell Dev Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1658444\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:29:40Z","timestamp":1758778180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1658444\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2025.1658444"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1658444","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"article-number":"1658444"}}